COMMUNIQUÉS West-GlobeNewswire
-
Cognition Therapeutics Invited to Participate in 2026 Jefferies Global Healthcare Conference
09/11/2026 -
BridgeBio to Participate in November and December Investor Conferences
09/11/2026 -
PharmAla Biotech Signs Supply and Data Agreement with Aalborg University Hospital for Danish Randomized Trial of MDMA-Assisted Treatment for Service-Related PTSD
09/11/2026 -
Cytokinetics Announces Additional Data Related to Aficamten Presented at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026
09/11/2026 -
Bicara Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
09/11/2026 -
Braveheart Bio to Participate in the Jefferies Global Healthcare Conference in London
09/11/2026 -
CervoMed Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
09/11/2026 -
Novo Nordisk A/S - share repurchase programme
09/11/2026 -
Foghorn Therapeutics Provides Third Quarter 2026 Financial and Corporate Update
09/11/2026 -
OrthoPediatrics Announces Full Commercial Launch of VerteGlide® Spinal Growth Guidance System
09/11/2026 -
NeurAxis Reports Record Third Quarter 2026 Financial Results Driven by 150% Year Over Year Revenue Growth
09/11/2026 -
Kamada Reports Record-High First Nine Months 2026 Financial Results; Increases 2026 Annual Guidance and Projects Double-Digit Growth in Revenues and Profitability in 2027
09/11/2026 -
Immunocore to present at upcoming investor conferences
09/11/2026 -
TRIDENT post-hoc analysis of low-dose triple combination therapy by kidney function in people with prior intracerebral hemorrhage presented at American Heart Association’s Scientific Sessions 2026
09/11/2026 -
Silexion Therapeutics Announces 1-for-24 Reverse Share Split
09/11/2026 -
Marengo Presents Interim Phase 2 STARt-002 Results for First-in-Class Selective T-Cell Agonist Invikafusp Alfa Plus Sacituzumab Govitecan Across Two Metastatic Breast Cancer Cohorts in Oral Presentation at SITC 2026
09/11/2026 -
Hemab Therapeutics Initiates SOLARA, a Pivotal Phase 3 Trial of Sutacimig in Glanzmann Thrombasthenia
09/11/2026 -
Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2026 on the Potential of MRT-8102 in Gout
09/11/2026 -
Editas Medicine Announces Third Quarter 2026 Results and Business Updates
09/11/2026
Pages